Microfluidic biosensor for rapid salmonella detection in chocolate matrices
A microfluidic biosensor leveraging Salmonella-specific antibodies offers rapid, on-site detection of Salmonella in complex chocolate matrices with high sensitivity and specificity, overcoming traditional detection challenges posed by chocolate's composition.
Overview
The microfluidic biosensor developed by the University of Alberta offers a breakthrough solution for the rapid detection of Salmonella in chocolate matrices. This innovative technology utilizes Salmonella-specific antibodies to achieve over 98% sensitivity and specificity, even in the complex composition of chocolate that typically hinders conventional detection methods. The biosensor addresses the challenges posed by chocolate's high fat content and low water activity, providing fast and reliable on-site testing within two hours.
Technical specifications
Key features:
- Microfluidic design: Utilizes channels redesigned to manage chocolate's viscosity, ensuring effective sample processing.
- Antibody functionalization: Incorporates Salmonella-specific antibodies, particularly targeting conserved outer membrane proteins (OMPs), for precise pathogen identification.
- Signal amplification: Optimizes enzymatic reactions for enhanced detection sensitivity using PNPP and maltose phosphorylase.
- Cost-effective: Delivers testing at less than €20 per test at scale, making it an affordable option for food safety compliance.
Technology readiness level
This biosensor is currently at Technology Readiness Level 5. It has undergone initial validation stages, with further field testing planned in chocolate production facilities to refine workflows and confirm its efficacy under real-world conditions. The technology is poised for deployment, aiming to enhance food safety standards and streamline pathogen detection in the chocolate industry.
About University of Alberta
The University of Alberta is a large, comprehensive public research university in Edmonton with multiple campuses and a strong applied research culture. Industry engages through co-located labs and pilot-scale facilities, as well as established co-op and internship programs that place talent with partners year-round. Integration with Alberta’s province-wide hospital system supports clinical research and accelerates translation. Companies also benefit from proximity to regional industry clusters and collaboration hubs on and near campus for joint R&D and prototyping. Supported by NSERC, CIHR, SSHRC, and Canada Foundation for Innovation funding—plus provincial and industry support—the tech transfer office manages IP, licensing, and startup formation with streamlined sponsored-research agreements.
delivered to your inbox.